Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg names Admiral among top picks in European insurance

(Sharecast News) - Berenberg analysts have named UK-listed motor insurer Admiral among their top picks in the European insurance sector. In a research note hailing the upside potential of the sector, the broker said rising free cash flow, operating profit growth and increasing top-line momentum are three key reasons to buy insurers across the board.

"Our positive outlook is supported by positive updates from the insurers we cover during our pre-close calls, when we were reminded of the sector's known strong trends, as well as the readacross from the Q1 2025 results of Travelers," Berenberg said.

"Our top picks remain Admiral, Allianz, AXA, NN Group and SCOR, to which we could also add Phoenix among the UK life insurers and Swiss Re among the larger reinsurers."

For Admiral specifically, Berenberg said the current share price - despite having gained 20% so far this year - still offers an "attractive opportunity to acquire a quality company at a discount".

"Q1 market pricing data indicates price deflation is slowing and with Aviva's acquisition of Direct Line and Ageas's Esure takeover, the sector looks to be consolidating at pace. The market should be more rational as a result, we believe," the broker said.

Berenberg expects Admiral's earnings per share growth to average 5% between 2025 and 2027, and the company's dividend to yield 6-7%.

The stock was up around 1% at 3,236p by 1335 GMT.

Share this article

Related Sharecast Articles

BioNTech to invest up to £1bn in UK R&D expansion
(Sharecast News) - BioNTech announced on Tuesday that it will invest up to £1bn over the next decade to expand its research and development footprint in the UK, backed by a government grant of up to £129m.
Image Scan warns on profits, shares slump
(Sharecast News) - Shares in Image Scan tumbled on Tuesday, after the X-ray screening specialist warned on profits following a "disappointing" first half.
Mosman Oil & Gas in talks to sell Billy Goat rights
(Sharecast News) - Mosman Oil and Gas said on Tuesday that it has been in talks with a local helium business interested in buying the first well and associated contractual rights of the Billy Goat area of mutual interest (AMI) lease at its Vecta Project in Colorado.
RBC Capital ups price target on Hikma
(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.